Cellular Biomedicine Group Stock News

Vident Investment Advisory LLC cut its stake in shares of Cellular Biomedicine Group Inc (NASDAQ:CBMG) by 24.0% in the 1st quarter, according to the company in its most recent filing with the Securiti

Regulatory News: Celyad SA (Euronext & Nasdaq: CYAD) (Brussels:CYAD) (Paris:CYAD) (NASDAQ:CYAD), une société biotechnologique de stade clinique fo

Q1 2020 Cellular Biomedicine Group Inc Earnings Call

Vivet Therapeutics meldete heute, dass sowohl die US-Food and Drug Administration (FDA) als auch die Europäische Kommission (EC) VTX-803, das zweite G

The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data. Insider Monkey finished processing 821 13F filing

Cellular Biomedicine Group Inc. (NASDAQ: CBMG) ("CBMG" or the "Company"), a biopharmaceutical firm engaged in the drug development of immunotherapies for cancer and stem cell therapies for degenerativ

The Janssen Pharmaceutical Companies of Johnson & Johnson today announced updated results from the Phase 1b/2 CARTITUDE-1 study (NCT03548207) eval

This week’s online annual meeting of the American Society for Gene and Cell Therapy will take place on the web.

Cellular Biomedicine Group, Inc. (NASDAQ:CBMG) Q1 2020 Earnings Conference Call May 06, 2020 05:00 PM ET Company Participants Derrick Li - Head-Strategy & I

May 07, 2020 (Global QYResearch via COMTEX) -- This report studies the global Mantle Cell Lymphoma Treatment market status and forecast, categorizes the...

Ladies and gentlemen, thank you for standing by, and welcome to the Cellular Biomedicine Group, Inc. First Quarter 2020 Results Conference Call. Speaking today is Chief Executive Officer and Chief Fi

The

Cellular Biomedicine Group Inc. (NASDAQ: CBMG) ("CBMG" or the "Company"), a biopharmaceutical firm engaged in the drug development of immunotherapies for cancer and stem cell therapies for degenerativ

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peak (Biotech Stocks Hitting 52-week Highs May 5) • Adverum Biotechnologies...